Nicholas Geraghty
Nicholas Geraghty
Verified email at uowmail.edu.au
Title
Cited by
Cited by
Year
Activation of the P2X7 receptor induces the rapid shedding of CD23 from human and murine B cells
A Pupovac, NJ Geraghty, D Watson, R Sluyter
Immunology and cell biology 93 (1), 77-85, 2015
202015
The P2X7 receptor antagonist Brilliant Blue G reduces serum human interferon‐γ in a humanized mouse model of graft‐versus‐host disease
NJ Geraghty, L Belfiore, D Ly, SR Adhikary, SJ Fuller, W Varikatt, ...
Clinical & Experimental Immunology 190 (1), 79-95, 2017
152017
P2X7 receptor in skin biology and diseases
N Geraghty, D Watson, S Adhikary, R Sluyter
122016
The P2X7 receptor is not essential for development of imiquimod-induced psoriasis-like inflammation in mice
NJ Geraghty, KJ Mansfield, SJ Fuller, D Watson, R Sluyter
Purinergic Signalling 13 (4), 405-415, 2017
102017
Increased splenic human CD4+: CD8+ T cell ratios, serum human interferon-γ and intestinal human interleukin-17 are associated with clinical graft-versus-host disease in …
NJ Geraghty, L Belfiore, SR Adhikary, SI Alexander, R Sluyter, D Watson
Transplant Immunology 54, 38-46, 2019
62019
Long-term treatment with the P2X7 receptor antagonist Brilliant Blue G reduces liver inflammation in a humanized mouse model of graft-versus-host disease
NJ Geraghty, D Watson, R Sluyter
Cellular Immunology 336, 12-19, 2019
52019
The P2X7 receptor antagonist JNJ-47965567 administered thrice weekly from disease onset does not alter progression of amyotrophic lateral sclerosis in SOD1 G93A mice
D Ly, A Dongol, P Cuthbertson, TV Guy, NJ Geraghty, RA Sophocleous, ...
Purinergic Signalling, 1-14, 2020
32020
Pharmacological blockade of the CD39/CD73 pathway but not adenosine receptors augments disease in a humanized mouse model of graft‐versus‐host disease
NJ Geraghty, D Watson, R Sluyter
Immunology and Cell Biology 97 (6), 597-610, 2019
32019
Altered donor P2X7 activity in human leukocytes correlates with P2RX7 genotype but does not affect the development of graft-versus-host disease in humanised mice
SR Adhikary, NJ Geraghty, P Cuthbertson, R Sluyter, D Watson
Purinergic signalling 15 (2), 177-192, 2019
32019
Comparison of peripheral blood mononuclear cell isolation techniques and the impact of cryopreservation on human lymphocytes expressing CD39 and CD73
RJ Turner, NJ Geraghty, JG Williams, D Ly, D Brungs, MG Carolan, ...
Purinergic Signalling, 1-13, 2020
2020
Telomere length varies substantially between blood cell types in a reptile
M Olsson, NJ Geraghty, E Wapstra, M Wilson
Royal Society Open Science 7 (6), 192136, 2020
2020
Streptococcus pyogenes M1T1 variants activate caspase-1 and induce an inflammatory neutrophil phenotype
JG Williams, D Ly, NJ Geraghty, JD McArthur, H Vyas, J Gorman, ...
bioRxiv, 2020
2020
Increased P2X7 expression in the gastrointestinal tract and skin in a humanised mouse model of graft-versus-host disease
P Cuthbertson, SR Adhikary, NJ Geraghty, TV Guy, A Hadjiashrafi, ...
Clinical Science 134 (2), 207-223, 2020
2020
The A2A receptor agonist CGS 21680 has beneficial and adverse effects on disease development in a humanised mouse model of graft-versus-host disease
NJ Geraghty, SR Adhikary, D Watson, R Sluyter
International Immunopharmacology 72, 479-486, 2019
2019
Increased splenic human CD4 (+): CD8 (+) T cell ratios
NJ Geraghty, L Belfiore, SR Adhikary, SI Alexander, R Sluyter, D Watson
2019
The Role of Purinergic Signalling in Inflammatory Disorders
NJ Geraghty
2019
Pro-inflammatory role of the ATP/P2X7 signalling axis in graft-versus-host disease in humanised mice
NJ Geraghty, SR Adhikary, P Cuthbertson, D Ly, T Guy, L Belfiore, ...
PURINERGIC SIGNALLING 14, S57-S58, 2018
2018
In Vivo Depletion of Dividing Donor Cells Using Post-Transplant Cyclophosphamide can Reduce the Development of Graft-Versus-Host Disease in a Humanised Mouse Model
S Adhikary, N Geraghty, S Alexander, R Sluyter, D Watson
Transplantation 102, S235, 2018
2018
The role of the P2X7 receptor in an imiquimod-induced psoriasis-like mouse model
N Geraghty, D Watson, S Fuller, V Sluyter, R Sluyter
EUROPEAN JOURNAL OF IMMUNOLOGY 46, 393-393, 2016
2016
P2X7 polymorphisms and the role of P2X7 in graft-versus-host disease
S Adhikary, N Geraghty, L Belfiore, S Alexander, R Sluyter, D Watson
EUROPEAN JOURNAL OF IMMUNOLOGY 46, 725-725, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–20